Previous close | 1.8000 |
Open | 1.1000 |
Bid | 0.4000 |
Ask | 0.5500 |
Strike | 210.00 |
Expiry date | 2024-05-17 |
Day's range | 0.5000 - 1.1000 |
Contract range | N/A |
Volume | |
Open interest | 582 |
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
Higher business-to-business sales aid Inogen's (INGN) overall first-quarter results.
STERIS' (STE) fourth-quarter performance in AST is dented by a decline in capital equipment revenues. The contraction of margins is concerning.